Treprostinil, a prostacyclin analog, mitigates profibrotic signaling in scleroderma fibroblasts via the EP2-PPARG-SMARCA4 pathway

Proceedings (Faculty180)

cited authors

  • Kahaleh, Bashar; Wang, Yongqing

authors

publication date

  • 2026

presented at event

start page

  • 121

volume

  • Abstract Book